Proneuron Biotechnologies
New York
About Proneuron Biotechnologies
Proneuron Biotechnologies develops spinal cord injury treatments, researches cures for paralysis, and neurological therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $10.0M
- Last round: Series Unknown (Dec 2001)
- Website: proneuron.com
- Phone: +1 212 758 9763
Industries & Categories
Biotechnology, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/proneuron-biotechnologies-2622839 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.